戻る Agenda
Digital Innovation is Revolutionising All Aspects of Trial Execution: Opportunities and Requirements
Session Chair(s)
Bill Byrom, PHD
Vice President, Product Intelligence and Positioning; Principal, eCOA Science
Signant Health , United Kingdom
Digital innovation is a key enabler in the drive to modernise clinical trials and make them faster, better and different. Technology promises to bring efficiency to our processes, insights for planning, richer information on interventions being studied, and new paradigms to simplify trial participation. How do we leverage these new approaches to gain efficiencies, increase the quality of clinical research and remain in compliance with current regulatory requirements and thinking?
Learning Objective : 1. Explain how the Common Protocol Template and protocol harmonization can benefit sites, regulators and sponsors. 2. Describe how TransCelerate’s technology enabled CPT facilitates protocol and enables content reuse, disclosure and other downstream processes. 3. Discuss considerations for implementation
Speaker(s)
Virtual Trials
Scott Askin, MSC
Novartis Pharma AG, Switzerland
Global Program Regulatory Director
TransCelerate's Common Protocol Template: Overview and Implementation Case Studies
Mitzi Allred, PHD
Merck & Co., Inc, United States
Director, Clinical Operations
Endpoints Using Wearables: How Do I Know Data Will Be Accepted?
Bill Byrom, PHD
Signant Health , United Kingdom
Vice President, Product Intelligence and Positioning; Principal, eCOA Science